2018 Webinar Series: Treatment of Substance Use Disorders in Primary Care

This complimentary webinar series, funded through a Wisconsin Medical Society Foundation grant, provides timely information and updates related to the treatment of substance use disorders. All presenters are local experts with a clear understanding of Wisconsin’s rural issues and barriers to care. CME is available for up to one year following each webinar recording date.

    Part 1:  Suboxone 2.0: Beyond the Basics; Ritu Bhatnagar, MD and John Ewing, MD, presenters

    Learning Objectives: Describe ways to talk non-judgmentally about adherence and sensitive issues related to buprenorphine; Develop strategies for ongoing management of patients on buprenorphine in the primary care setting.

    Recording date: June 20, 2018 | View Webinar  (CME is no longer available for this session)

    Part 2: Interpretation of Urine Drug Screen; David Galbis-Reig, MD, presenter

    Learning Objectives: Discuss the history of drug testing and its introduction into clinical practice; Describe the different drug testing matrices and the potential advantages and disadvantages of each in clinical practice; Understand the basics of urine drug testing: What to test, how to test, and in what situations to perform a urine drug screen; Understand the limitations of urine drug testing; Understand how to interpret a positive urine immunoassay and when to obtain confirmatory tests.

    Recording date: July 18, 2018 | View Webinar  (CME is no longer available for this session)

    Part 3: Treatment of Stimulant Disorder; Mark Lim, MD, presenter

    Learning Objectives: Discuss appropriate treatment strategies for patients with stimulant disorder; Understand the limitations of combination pharmacotherapies for the management of stimulant disorder. 

    Recording Date: August 15, 2018 | View Webinar  (CME is no longer available for this session)

    Part 4: Treatment of Alcohol Use and Opioid Use Disorder in Pregnancy, presented by Jacquelyn Adams, MD 

    Learning Objectives: Describe opioid use disorder and alcohol use disorder in pregnancy; Understand risks of withdrawal in pregnancy; Discuss current treatment standards and possible new therapies specific to pregnancy.

    Recording Date: October 17, 2018 | View Webinar  (CME is no longer available for this session)

    Part 5: Treatment and Withdrawal Management of Alcohol Use Disorder, presented by Tim Cordes, MD

    Learning Objectives: Identify elements from a patient’s history and presentation that suggest the potential for more symptomatic alcohol withdrawal; Describe medications which are used for management of outpatient alcohol withdrawal; List indications for and common risks of naltrexone for alcohol use disorder.
    Recording Date: May 3, 2019 | View Webinar (CME is no longer available for this session)


    Contact WISAM

    563 Carter Court, Suite B
    Kimberly, WI 54136
    920-750-7727
    WISAM@badgerbay.co


    Social Media Center

    Copyright © 2018 WISAM All rights reserved.  | Terms of Use | Privacy Policy

    The Wisconsin Society of Addiction Medicine (WISAM) is headquartered in Kimberly, WI.
    Contact us today for more information about our organization!

    Powered by Wild Apricot Membership Software